ILUM Tec

What ILUM Tec does

ILUM Tec GmbH is a privately held Vienna-based investment company that acquires and supports early-stage Central European companies in life sciences and high technology, with a stated special emphasis on regenerative medicine. The firm invests at the seed and follow-on stages, targeting strong minority interests, and pursues two strategic outcomes: value enhancement culminating in exit or M&A, and growth via further capital rounds with a possible IPO and profit distributions. Its portfolio of seven companies spans vascular and endovascular prostheses that mimic the elasticity of healthy aortic tissue (Ascense Medical), auricular vagus nerve stimulation for drug-free chronic-pain treatment (AURIMOD/VIVO), an AI-driven computer-vision platform that converts musculoskeletal X-ray images into diagnostic findings and is live at more than 160 sites in Europe and the US (ImageBiopsy Lab), regenerative grafts from medical silk and a patented autologous stem-cell concentrate process (MorphoMed), industrial high-precision micro-component manufacturing via 3D printing and micro injection molding (NanoVoxel), combination stem-cell-and-biomaterial therapy for acute spinal cord injuries (Regenera), and high-resolution 3D printing systems with 150-nanometer structural detail (UpNano's NanoOne). Beyond capital, ILUM Tec operates an in-house Service Center delivering administrative, financial planning, controlling, accounting, legal, quality management, regulatory affairs, and US market-entry support, and actively leverages Austrian and European subsidies and funding programs to extend investment reach. The shareholder base comprises IGO Innovation, the Ortner family, KHtec (Klemens Hatschek), OnePharm (Udo Elsner and Bernhard Küenburg), and additional unnamed investors; the management team is led by Dr. Bernhard Küenburg as Managing Director, Mag. Anton Travnicek as CFO, with Dr. Udo Elsner on legal, Dr. Michael Hammerschmid on quality and processes, and Erika Bechtold, PhD on US business support. The firm does not disclose revenues, AUM, fund size, or exit history in the public record.

Name

ILUM Tec

Legal name

ILUM Tec GmbH

Website

https://ilumtec.at

Company type

Private

Operating status

Operating

Short description

ILUM Tec GmbH is a Vienna-based private investment company that provides seed and follow-on financing to Central European startups in life sciences and high technology, with a special focus on regenerative medicine, currently holding minority stakes in seven portfolio companies across AI diagnostics, vascular prostheses, neuromodulation, regenerative medicine, and 3D printing.

Ownership category

akta.pro rank

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others, Technology or R&D

Revenue model

1. Investment Returns and Exit Proceeds: ILUM Tec generates returns through value enhancement of portfolio companies with the goal of exit or M&A transactions, and growth through further capital rounds and possible IPO with attractive ROI through profit distributions.

Distribution channels1 record

Marketing channels2 records

Core offering

ILUM Tec GmbH is a private Vienna-based investment/holding company that acquires minority equity stakes in attractive Central European life-science and high-technology startups, with a special emphasis on regenerative medicine. The firm provides seed and follow-up financing to a portfolio of seven companies (Ascense Medical, AURIMOD, ImageBiopsy Lab, MorphoMed, NanoVoxel, Regenera, and UpNano) and supplements capital with the ILUM Tec Services support platform, delivering administrative, financial planning, controlling, accounting, legal, quality management, regulatory, and US market expertise.

Product overview

ILUM Tec is an investment company (not a product company) that invests in attractive Central European companies in life science and high technology, with special focus on regenerative medicine. Its portfolio consists of seven portfolio companies: Ascense Medical (vascular prostheses), AURIMOD (VIVO pain treatment device), ImageBiopsy Lab (AI diagnostic platform), MorphoMed (regenerative silk grafts), NanoVoxel (micro component manufacturing), Regenera (stem cell therapy), and UpNano (high-resolution 3D printing systems). ILUM Tec provides seed and follow-up financing, targeting strong minority interests with comprehensive support services.

Differentiator

Problem solved

Functional benefit

Products and services

• ILUM Tec Services Comprehensive support services offered by ILUM Tec to its portfolio companies, covering administrative services, financial planning, controlling, accounting, legal support, quality management, regulatory issues, and US market entry expertise to help portfolio startups scale and succeed.

Named customers7 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Speedinvest: Vienna-based early-stage VC investing across European technology and deep-tech startups, including health/biotech verticals. Directly comparable as a Central European VC with overlapping geographic footprint and stage focus.
• Earlybird Venture Capital: Pan-European early- and growth-stage VC with significant exposure to healthtech, biotech, and deep tech. Directly comparable on investment stage and sector overlap.
• Coparion: Cologne-based VC supporting German and European technology and life-sciences startups, with active involvement in management. Comparable on regional focus and active-support investment model.
• btov Partners: European VC firm investing in deep tech, industrial tech, and digital health startups from early stage onward. Comparable on the high-tech industrial and medical device portfolio overlap.
• HTGF (High-Tech Gründerfonds): Germany's leading seed investor in high-tech startups, including life sciences, with extensive portfolio across medical devices and deep tech. Closely comparable as a regional seed-stage investor with similar ticket sizes and support model.
• Forbion: Leading European life-sciences VC with focus on biotech, medical devices, and regenerative medicine. Directly comparable given ILUM Tec's regenerative-medicine specialty and life-sciences weighting.
• LSP (Life Sciences Partners): Amsterdam-based European life-sciences VC with deep biotech and medical-device franchise. Comparable on dedicated life-sciences investment focus and European footprint.
• MIG Capital: Munich-based VC and growth investor in life sciences and high-tech companies, including biotech, medtech, and deep tech. Directly comparable as a German-speaking European investor in the same sectors as ILUM Tec.
• Wellington Partners: European technology and life-sciences VC investing from seed through growth stages. Highly comparable given overlap in medical devices, biotech, and deep-tech investment theses across European markets.

Regional players

• Austria Wirtschaftsservice Gesellschaft (aws): Austrian federal promotional bank providing venture capital and growth financing to Austrian technology and life-sciences startups. Comparable as a domestic Austrian capital provider, though structured as a public development bank rather than private VC.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ILUM Tec